{"database": "lobbying", "table": "lobbying_activities", "rows": [[1182242, "aeddcfc6-144d-4d58-b0c6-6491cc21527f", "Q4", "AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS", 3457, "AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS", 2011, "fourth_quarter", "PHA", "H.R. 2245, S. 296, \"Preserving Access to Life-Saving Medications Act,\" all provisions. Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on dietary supplements, long-acting opiods, Prescription Drug User Fee Act presentation at FDA public meeting. Communications with the National Institute for Occupational Safety and Health (NIOSH) on their proposed list of hazardous drugs for 2012. Support for S. 1584, \"The Drug Safety and Accountability Act,\" a bill to ensure drug supply safety and give FDA mandatory recall authority.", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 250000, 0, 0, "2012-01-06T14:56:12-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1182242"], "units": {}, "query_ms": 0.35725790075957775, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}